1. Blencowe H, Cousens S, Chou D, Oestergaard M, Say L, Moller AB, et al. Born too soon: the global epidemiology of 15 million preterm births. Reprod Health 2013; 10 (Suppl.): S2. [
DOI:10.1186/1742-4755-10-S1-S2] [
PMID] [
PMCID]
2. Muglia LJ, Katz M. The enigma of spontaneous preterm birth. N Engl J Med 2010; 362: 529-535. [
DOI:10.1056/NEJMra0904308] [
PMID]
3. Beck S, Wojdyla D, Say L, Betran AP, Merialdi M, Requejo JH, et al. The worldwide incidence of preterm birth: a systematic review of maternal mortality and morbidity. Bull World Health Organ 2010; 88: 31-38. [
DOI:10.2471/BLT.08.062554] [
PMID] [
PMCID]
4. Hassan SS, Romero R, Vidyadhari D, Fusey S, Baxter JK, Khandelwal M, et al. Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol 2011; 38: 18-31. [
DOI:10.1002/uog.9017] [
PMID] [
PMCID]
5. Conde-Agudelo A, Romero R, Kusanovic JP. Nifedipine in the management of preterm labor: a systematic review and meta analysis. Am J Obstet Gynecol 2011; 204: 134: e1-20. [
DOI:10.1016/j.ajog.2010.11.038] [
PMID] [
PMCID]
6. Romero R, Yeo L, Chaemsaithong P, Chaiworapongsa T, Hassan SS. Progesterone to prevent spontaneous preterm birth. Semin Fetal Neonatal Med 2014; 19: 15-26. [
DOI:10.1016/j.siny.2013.10.004] [
PMID] [
PMCID]
7. Moramezi F, Barati M, Saadati N, Masihi S, Hemadi M. A comparative study between the efficacy of 17-alpha hydroxyl progesterone caproate plus salbutamol with magnesium sulfate in treatment of preterm labor. Int J Pharmacol 2011; 7: 130-134. [
DOI:10.3923/ijp.2011.130.134]
8. Beigi A, Esmailzadeh A, Pirjani R. Comparison of risk of preterm labor between vaginal progesterone and17-alpha-hydroxy-progesterone Caproate in women with threatened abortion: A randomized clinical trial. Int J Fertil Steril 2016; 10: 162-168.
9. Yassaee F, Shekarriz Foumani R, Afsari S, Fallahian M. The effect of progesterone suppositories on threatened abortion: A randomized clinical trial. J Reprod Infertil 2014; 15: 147-151.
10. Ragunath MP, Sasmal D, Dhanaraj M. A study of nifedipine in the treatment of preterm labor of south Indian origin. Int J Pharm Res Scholar 2012; 1: 34-38. [
DOI:10.31638/IJPRS.V1.I1.00015]
11. Klauser CK, Briery CM, Martin RW, Langston L, Magann EF, Morrison JC. A comparison of three tocolytics for preterm labor: a randomized clinical trial. J Matern Fetal Neonatal Med 2014; 27: 801-806. [
DOI:10.3109/14767058.2013.847416] [
PMID]
12. Sharami SH, Zahiri Z, Shakiba M, Millani F. Maintenance therapy by vaginal progesterone after threatened idiopathic preterm labor: A randomized placebo controlled double blind trial. Int J Fertil Steril 2010; 4: 45-50.
13. Saleh Gargari S, Habibolahi M, Zonobi Z, Khani Z, Sarfjoo FS, Kazemi Robati A, et al. Outcome of vaginal progesterone as a tocolytic agent: Randomized clinical trial. ISRN Obstet Gynecol 2012; 2012: 607906. 1-5. [
DOI:10.5402/2012/607906] [
PMID] [
PMCID]
14. Kashanian M, Bahasadri S, Zolali B. Comparison of the efficacy and adverse effects of nifedipine and indomethacin for the treatment of preterm labor. Int J Gynecol Obstet 2011; 113: 192-195. [
DOI:10.1016/j.ijgo.2010.12.019] [
PMID]
15. Khan K, Zamora J, Lamont RF, Van Geijn Hp H, Svare J, Santos-Jorge C, et al. Safety concerns for the use of calcium channel blockers in pregnancy for the treatment of spontaneous preterm labour and hypertension: a systematic review and meta-regression analysis. J Matern Fetal Neonatal Med 2010; 23: 1030-1038. [
DOI:10.3109/14767050903572182] [
PMID]
16. Flenady V, Wojcieszek AM, Papatsonis DN, Stock OM, Murray L, Jardine LA, et al. Calcium channel blockers for inhibiting preterm labour and birth. Cochrane Database Syst Rev 2014; 6: CD002255. [
DOI:10.1002/14651858.CD002255.pub2]
17. Gáspár R, Hajagos-Tóth J. Calcium channel blockers as tocolytics: principles of their actions, adverse effects and therapeutic combinations. Pharmaceuticals 2013; 6: 689-699. [
DOI:10.3390/ph6060689] [
PMID] [
PMCID]
18. Bomba-Opon DA, Kosinska-Kaczynska K, Kosinski P, Wegrzyn P, Kaczynski B, Wielgos M. Vaginal progesterone after tocolytic therapy in threatened preterm labor. J Matern Fetal Neonatal Med 2012; 25: 1156-1159. [
DOI:10.3109/14767058.2011.629014] [
PMID]
19. Arikan I, Barut A, Harma M, Harma IM. Effect of progesterone as a tocolytic and in maintenance therapy during preterm labor. Gynecol Obstet Invest 2011; 72: 269-273. [
DOI:10.1159/000328719] [
PMID]
20. Bafghi AS, Bahrami E, Sekhavat L. Comparative study of vaginal versus intramuscular progesterone in the prevention of preterm delivery: A randomized clinical trial. Electron Physician 2015; 7: 1301-1309.